Patrick F. Kelly,Alan Collis,Jeff Davis,Duncan Walker,Susan Ashwell,Blythe Thomson
申请号：
US16414505
公开号：
US20190350919A1
申请日:
2019.05.16
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Methods of treating patients diagnosed with cancer harboring an IDH-1 mutation are provided, including the therapeutic administration of a certain inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA).
